-
Study aim
-
The effect of Propofol-Thiopental and Propofol-Etomidate combination on sedation and hemodynamic status of the patient in cataract surgery
-
Design
-
Clinical trial with control group, with parallel groups, double-blind, randomized, phase 3 on 64 patients. Lottery and sealed envelopes are used for randomization.
-
Settings and conduct
-
This is a randomized double-blind clinical trial that will be performed on 64 patients undergoing cataract surgery at Feyz Hospital in Isfahan; After the approval of the university ethics committee and obtaining the patients' consent, the patients entered the groups by random allocation. In each group, the desired intervention is applied and the patient's clinical symptoms are recorded. They do not know the type of intervention. Patients, despite being studied, are not aware of the type of intervention and are therefore all blind.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patients 18 to 60 years old, Candidate for Cataract Surgery, Class I and II ASA Anesthesia
Exclusion criteria: heart disease, mental illness, obesity, diabetes, drug allergies and addiction
-
Intervention groups
-
Intervention group A: In this group, patients receive 1 mg per kg of body weight of Propofol-Thiopental sodium for anesthesia.
Intervention group B: In this group, patients receive 0.3 mg per kg of body weight of Propofol-Etomidate for anesthesia.
-
Main outcome variables
-
The amount of patient sedation during the operation; The rate of hemodynamic changes in the patient